Driving reinvestment in R&D for antibiotics and advocating their responsible use

DRIVE-AB Participants Comment on UK Review on AMR Report

In response to the Review on Antimicrobial Resistance report that was released today, “Securing new drugs for future generations: The pipeline of antibiotics“, three  DRIVE-AB members, one external Work Package 2 partner and two participants of the Work Package 3B Stakeholder Platform and External Communication group, have released commentaries on the recommendations put forth by the Review.

The Review on Antimicrobial Resistance makes bold recommendations to address the issue of incentivising research and development of new antibiotics on a global scale. Prof Kevin Outterson, Dr Charles Clift, and Prof Laura Piddock provide comments on these recommendations:

 “Saving the world, one antibiotic at a time” – Kevin Outterson, WP2 External Partner, Boston School of Law and Chatham House



Photo Charles CliftDe-linkage: A Way Forward for Antimicrobial Drugs” – Charles Clift, WP3B, Chatham House



Photo Laura PiddockResponse to O’Neill AMR Review report 14th May 2015” – Laura JV Piddock, WP3B, British Society for Antimicrobial Chemotherapy, Antibiotic Action, University of Birmingham



Back to Commentaries

Back to DRIVE-AB Publications